Guangdong Hybribio Biotech Co.,Ltd.

SZSE:300639 Stock Report

Market Cap: CN¥4.1b

Guangdong Hybribio BiotechLtd Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jianyu Wang

Chief executive officer

CN¥2.0m

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenure7.3yrs
Board average tenure7.9yrs

Recent management updates

Recent updates

Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Oct 08
Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Is Guangdong Hybribio BiotechLtd (SZSE:300639) Using Debt In A Risky Way?

Sep 29
Is Guangdong Hybribio BiotechLtd (SZSE:300639) Using Debt In A Risky Way?

Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) 77% Share Price Surge Not Quite Adding Up

Aug 19
Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) 77% Share Price Surge Not Quite Adding Up

Guangdong Hybribio BiotechLtd (SZSE:300639) Is Reducing Its Dividend To CN¥0.065

May 22
Guangdong Hybribio BiotechLtd (SZSE:300639) Is Reducing Its Dividend To CN¥0.065

There May Be Some Bright Spots In Guangdong Hybribio BiotechLtd's (SZSE:300639) Earnings

May 03
There May Be Some Bright Spots In Guangdong Hybribio BiotechLtd's (SZSE:300639) Earnings

CEO

Jianyu Wang (63 yo)

2.3yrs

Tenure

CN¥2,028,700

Compensation

Ms. Jianyu Wang is the General Manager at Guangdong Hybribio Biotech Co.,Ltd. since August 31, 2022 and was its Executive Deputy General Manager until August 31, 2022. She has been Director at Guangdong Hy...


Leadership Team

NamePositionTenureCompensationOwnership
Jianyu Wang
GM & Director2.3yrsCN¥2.03mno data
Qinghui Li
Finance Director & Accounting Supervisor10.7yrsCN¥671.50k0.0072%
CN¥ 291.9k
Longxu Xie
Deputy GM & Director14.3yrsCN¥1.15m0.059%
CN¥ 2.4m
Zhisheng Guan
Executive Deputy GM & Non Independent Directorno dataCN¥2.97m0.57%
CN¥ 23.3m
Yi Chen
Deputy GM & Board Secretaryno dataCN¥715.90k0.013%
CN¥ 519.0k
Danrong Weng
Deputy General Manager3.9yrsCN¥720.50k0.0056%
CN¥ 226.7k

7.3yrs

Average Tenure

49.5yo

Average Age

Experienced Management: 300639's management team is seasoned and experienced (7.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jianyu Wang
GM & Director8.3yrsCN¥2.03mno data
Longxu Xie
Deputy GM & Director4.2yrsCN¥1.15m0.059%
CN¥ 2.4m
Zhisheng Guan
Executive Deputy GM & Non Independent Director14.3yrsCN¥2.97m0.57%
CN¥ 23.3m
Meilan Qiu
Supervisor7.5yrsno datano data
Weixiong Huang
Vice Chairman of the Board14.3yrsCN¥300.00kno data
Xiaoyan Yang
Director14.3yrsCN¥120.00kno data
Qiaozhong Guan
Chairman of the Board14.3yrsCN¥2.17mno data
Wanjian Xu
Employee Representative Supervisor11.3yrsno datano data
Ruijun Ma
Chairman of the Supervisory Board5.3yrsno datano data
Youlin Qiao
Independent Director2.3yrsCN¥120.00kno data
Chunxue Yang
Independent Director2.3yrsCN¥120.00kno data
Yingshi Chen
Independent Director2.3yrsCN¥120.00kno data

7.9yrs

Average Tenure

60.5yo

Average Age

Experienced Board: 300639's board of directors are considered experienced (7.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:13
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangdong Hybribio Biotech Co.,Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hanqing ZhuGuosen Securities Co., Ltd.
Jiaxi XuIndustrial Securities Co. Ltd.
Jiaqi ZhuZhongtai Securities Co. Ltd.